Skip to main content

Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review.


AUTHORS

Yilmaz TTaygan , Weaver CD Christopher D , Gallagher MJ Micheal J , Cordero-Coma M Miguel , Cervantes-Castaneda RA Rene A , Klisovic D Dino , Lavaque AJ Alejandro J , Larson RJ Robin J . Ophthalmology. 2009 5 ; 116(5). 902-11; quiz 912-3

ABSTRACT

To compare intravitreal triamcinolone acetonide (IVTA) injection versus no treatment or sub-Tenon triamcinolone acetonide (STTA) injection in improving visual acuity (VA) of patients with refractory diabetic macular edema (DME; unresponsive to focal laser therapy).


To compare intravitreal triamcinolone acetonide (IVTA) injection versus no treatment or sub-Tenon triamcinolone acetonide (STTA) injection in improving visual acuity (VA) of patients with refractory diabetic macular edema (DME; unresponsive to focal laser therapy).